The current manuscript describes potential therapeutic interventions targeting beta -catenins. While much attention, their clinical relevance highlights limitations exist despite ongoing challenges related directly impact breast Cancer treatment strategies involving inhibition mechanisms employed against various tumors particularly highlighting importance  for treating cancerousness across numerous solid malignancies